当前位置: X-MOL 学术Eur. J. Med. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents
European Journal of Medicinal Chemistry ( IF 6.0 ) Pub Date : 2020-09-28 , DOI: 10.1016/j.ejmech.2020.112874
Min Wang 1 , Tongtong Liu 1 , Shiming Chen 1 , Mingfei Wu 1 , Jianfei Han 1 , Zeng Li 1
Affiliation  

Pleiotropic intervention has prominent advantages for complex pathomechanisms, such as Alzheimer’s disease (AD). In this study, a series of novel 3-(4-pyridyl)-5-(4- sulfamido-phenyl)-1,2,4-oxadiazole derivatives were designed and synthesized following the multitarget-directed ligand-based strategy. All compounds were evaluated for glycogen synthase kinase 3β (GSK-3β) inhibition and antineuroinflammatory and neuroprotective activities. Given that abnormal glucose metabolism plays an important role in AD occurrence and development, the effects of all compounds on glucose consumption in HepG2 cells was evaluated. Compounds 5e and 10b showed good dual potency in GSK-3β inhibition (IC50: 5e = 1.52 μM, 10b = 0.19 μM) and antineuroinflammatory potency (IC50: 5e = 0.47 ± 0.64 μM, 10b = 6.94 ± 2.33 μM). The effect of compound 10b on glucose consumption was higher than that of positive drug metformin. These compounds exerted a certain neuroprotective effect. Compound 10b dramatically reduced Aβ-induced Tau hyperphosphorylation, thus inhibiting GSK-3β at the cellular level. Notably, compounds 5e and 10b exhibited good inhibitory effects on the formation of intracellular reactive oxygen species (ROS). Moreover, these compounds displayed proper blood–brain barrier permeability and lacked neurotoxicity up to 50 μM concentration. Finally, in vivo experiments revealed that compound 10b improved cognitive impairment in scopolamine-induced mouse models. Results indicated that compound 10b deserves further study as a multifunctional lead compound.



中文翻译:

作为新型GSK-3β抑制剂的3-(4-吡啶基)-5-(4-磺酰胺基-苯基)-1,2,4-恶二唑衍生物的设计与合成及其作为多功能抗阿尔茨海默病药物的潜力评估

多发性干预对于复杂的病理机制(例如阿尔茨海默氏病(AD))具有突出的优势。在这项研究中,遵循多目标导向的基于配体的策略,设计并合成了一系列新型的3-(4-吡啶基)-5-(4-磺酰胺基-苯基)-1,2,4-恶二唑衍生物。评价所有化合物对糖原合酶激酶3β(GSK-3β)的抑制作用,抗神经炎和神经保护活性。考虑到异常葡萄糖代谢在AD的发生和发展中起着重要作用,因此评估了所有化合物对HepG2细胞葡萄糖消耗的影响。化合物5e10b在抑制GSK-3β方面显示出良好的双重功效(IC 505e  = 1.52μM,10b = 0.19μM)和抗神经炎效力(IC 505e  = 0.47±0.64μM,10b  = 6.94±2.33μM)。化合物10b对葡萄糖消耗的影响高于阳性药物二甲双胍。这些化合物发挥了一定的神经保护作用。化合物10b显着降低了Aβ诱导的Tau过度磷酸化,从而在细胞水平上抑制了GSK-3β。值得注意的是,化合物5e10b对细胞内活性氧(ROS)的形成表现出良好的抑制作用。此外,这些化合物显示出适当的血脑屏障通透性,并且在浓度高达50μM时缺乏神经毒性。最后,体内实验表明,化合物10b可改善东pol碱诱导的小鼠模型中的认知障碍。结果表明,化合物10b作为多功能铅化合物值得进一步研究。

更新日期:2020-10-04
down
wechat
bug